Studying a powder to reduce bleeding in knee replacement
Part of Bones, joints & muscles clinical trials.
This trial tests a powder called SURGICEL® that may help control bleeding during knee replacement surgery. People with severe knee arthritis who are having their first knee replacement may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have severe knee arthritis that hasn't gotten better with other treatments, and are scheduled for a first-time knee replacement.
- Your knee is not too bent or deformed (flexion less than 30 degrees, varus less than 20 degrees, or valgus less than 10 degrees).
- You are having open surgery (not with a robot or computer navigation).
- You do not have a bleeding disorder or take blood thinners that can't be stopped for a short time before surgery.
- You do not have serious heart, lung, liver, kidney, or blood problems, and have not had a stroke or cancer in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies changes in joint fluid before and after a procedure called genicular artery embolization (GAE) for knee osteoarthritis. It aims to understand how the procedure works to reduce pain and improve knee function.
This study tests whether taking collagen peptides can improve how knee tissues heal and remodel after total knee arthroplasty (knee replacement). It also looks at functional recovery and wound healing, especially during the physical therapy period in Little Rock.
This trial tests a procedure called genicular artery embolization, which blocks small blood vessels around the knee to reduce pain from moderate arthritis. It may help people whose knee pain hasn't improved with medications.
This study compares two minimally invasive procedures—embolization (blocking blood flow) and nerve ablation (blocking pain signals)—to see which works better for knee osteoarthritis pain. If you have long-lasting knee pain and are considering knee replacement surgery, this trial may help find another option.
This trial tests an experimental drug called BT-114143 to see if it reduces bleeding during and after total knee replacement surgery. It may be a good option for people with osteoarthritis who are having their first knee replacement.
This trial tests a non-surgical treatment called microparticle geniculate artery embolization for people with persistent knee pain after a total knee replacement. It aims to reduce pain by blocking tiny blood vessels that may be causing inflammation.
Hear when a new Knee Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.